NDC 62856-601

Panretin

Alitretinoin

Panretin is a Topical Gel in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Alitretinoin.

Product ID62856-601_50ab2ed7-651c-4952-91d6-5011709ae429
NDC62856-601
Product TypeHuman Prescription Drug
Proprietary NamePanretin
Generic NameAlitretinoin
Dosage FormGel
Route of AdministrationTOPICAL
Marketing Start Date2009-02-03
Marketing CategoryNDA / NDA
Application NumberNDA020886
Labeler NameEisai Inc.
Substance NameALITRETINOIN
Active Ingredient Strength60 mg/60g
Pharm ClassesRetinoid [EPC],Retinoids [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 62856-601-22

60 g in 1 TUBE (62856-601-22)
Marketing Start Date2009-02-03
Marketing End Date2021-10-31
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 62856-601-22 [62856060122]

Panretin GEL
Marketing CategoryNDA
Application NumberNDA020886
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2009-02-03
Marketing End Date2021-10-31

Drug Details

Active Ingredients

IngredientStrength
ALITRETINOIN60 mg/60g

OpenFDA Data

SPL SET ID:13c5de6d-d266-4d83-99c4-072ef104e7ff
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 213502
  • 313847
  • Pharmacological Class

    • Retinoid [EPC]
    • Retinoids [CS]

    NDC Crossover Matching brand name "Panretin" or generic name "Alitretinoin"

    NDCBrand NameGeneric Name
    59212-601PANRETINalitretinoin
    62856-601PanretinAlitretinoin

    Trademark Results [Panretin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    PANRETIN
    PANRETIN
    74700355 2149627 Live/Registered
    EISAI INC.
    1995-07-12

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.